186 related articles for article (PubMed ID: 8914876)
1. Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).
Pitt B; Chang P; Grossman W; Dunlay M; Timmermans PB
Am J Cardiol; 1996 Nov; 78(10):1129-31. PubMed ID: 8914876
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
Pitt B; Chang P; Timmermans PB
Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological demonstration of the additive effects of angiotensin-converting enzyme inhibition and angiotensin II antagonism in sodium depleted healthy subjects.
Azizi M; Guyene TT; Chatellier G; Ménard J
Clin Exp Hypertens; 1997; 19(5-6):937-51. PubMed ID: 9247766
[TBL] [Abstract][Full Text] [Related]
7. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
[TBL] [Abstract][Full Text] [Related]
8. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
White M; Rouleau JL; Afzal R; Floras J; Yusuf S; McKelvie RS
Ther Adv Cardiovasc Dis; 2009 Apr; 3(2):113-21. PubMed ID: 19299427
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibitors in heart failure: prospects and limitations.
Pitt B
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():285-90. PubMed ID: 9211022
[TBL] [Abstract][Full Text] [Related]
10. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
11. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.
Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J
Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
[TBL] [Abstract][Full Text] [Related]
13. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure.
Guazzi M; Palermo P; Pontone G; Susini F; Agostoni P
Am J Cardiol; 1999 Nov; 84(9):1038-43. PubMed ID: 10569660
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
Blanchet M; Sheppard R; Racine N; Ducharme A; Curnier D; Tardif JC; Sirois P; Lamoureux MC; De Champlain J; White M
Am Heart J; 2005 May; 149(5):938.e1-7. PubMed ID: 15894946
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice.
Takai S; Song K; Tanaka T; Okunishi H; Miyazaki M
Life Sci; 1996; 59(21):PL331-6. PubMed ID: 8937511
[TBL] [Abstract][Full Text] [Related]
16. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.
Jacobsen P; Andersen S; Rossing K; Jensen BR; Parving HH
Kidney Int; 2003 May; 63(5):1874-80. PubMed ID: 12675866
[TBL] [Abstract][Full Text] [Related]
17. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
[TBL] [Abstract][Full Text] [Related]
18. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
Davie AP; Dargie HJ; McMurray JJ
Circulation; 1999 Jul; 100(3):268-73. PubMed ID: 10411851
[TBL] [Abstract][Full Text] [Related]
19. [Use of angiotensin II receptor blockaders in heart failure].
Bonarjee VV; Dickstein K
Tidsskr Nor Laegeforen; 2000 Mar; 120(7):817-21. PubMed ID: 10806906
[TBL] [Abstract][Full Text] [Related]
20. [ACE inhibitors or AT1 receptor antagonists?].
Riegger GA
Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
[No Abstract] [Full Text] [Related]
[Next] [New Search]